These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10649624)

  • 1. Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate.
    Wang S; Liu X; Fisher K; Smith JG; Chen F; Tobery TW; Ulmer JB; Evans RK; Caulfield MJ
    Vaccine; 2000 Jan; 18(13):1227-35. PubMed ID: 10649624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant synergy in the response to hepatitis B vaccines.
    Wang S; Liu X; Caulfield MJ
    Vaccine; 2003 Oct; 21(27-30):4297-306. PubMed ID: 14505912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response.
    Kwissa M; Lindblad EB; Schirmbeck R; Reimann J
    J Mol Med (Berl); 2003 Aug; 81(8):502-10. PubMed ID: 12879151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enhancement of a hepatitis B DNA vaccine potency using aluminum phosphate in mice].
    Liang ZW; Ren H; Lang YH; Li YG
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):79-81. PubMed ID: 14980105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12.
    Schirmbeck R; Reimann J
    Intervirology; 2001; 44(2-3):115-23. PubMed ID: 11509872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic lipid DC-Chol induces an improved and balanced immunity able to overcome the unresponsiveness to the hepatitis B vaccine.
    Brunel F; Darbouret A; Ronco J
    Vaccine; 1999 Apr; 17(17):2192-203. PubMed ID: 10367954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemokinin-1 as an adjuvant molecule enhancing humoral and memory responses to HBsAg DNA vaccination.
    Chen X; Zhang W; Gao W; Zou Q; Feng C; Liu H; Zhou C; Zhang Y; Wang B
    Viral Immunol; 2012 Aug; 25(4):289-96. PubMed ID: 22876773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
    Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
    Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated immune response to DNA vaccines.
    Zhang L; Widera G; Bleecher S; Zaharoff DA; Mossop B; Rabussay D
    DNA Cell Biol; 2003 Dec; 22(12):815-22. PubMed ID: 14683592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model.
    Mahdavi M; Mavandadnejad F; Yazdi MH; Faghfuri E; Hashemi H; Homayouni-Oreh S; Farhoudi R; Shahverdi AR
    J Infect Public Health; 2017; 10(1):102-109. PubMed ID: 27026241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immunogenicity of DNA fusion vaccine encoding secreted hepatitis B surface antigen and chemokine RANTES.
    Kim SJ; Suh D; Park SE; Park JS; Byun HM; Lee C; Lee SY; Kim I; Oh YK
    Virology; 2003 Sep; 314(1):84-91. PubMed ID: 14517062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
    Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen.
    Schirmbeck R; Wild J; Stober D; Blum HE; Chisari FV; Geissler M; Reimann J
    J Immunol; 2000 Apr; 164(8):4235-43. PubMed ID: 10754320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.
    McCluskie MJ; Weeratna RD; Payette PJ; Davis HL
    FEMS Immunol Med Microbiol; 2002 Feb; 32(3):179-85. PubMed ID: 11934561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide.
    Schirmbeck R; König-Merediz SA; Riedl P; Kwissa M; Sack F; Schroff M; Junghans C; Reimann J; Wittig B
    J Mol Med (Berl); 2001 Jun; 79(5-6):343-50. PubMed ID: 11485031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boosting immune response to hepatitis B DNA vaccine by coadministration of Prothymosin alpha-expressing plasmid.
    Jin Y; Cao C; Li P; Liu X; Huang W; Li C; Ma Q
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1364-9. PubMed ID: 16339058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of DNA vaccine potency using conventional aluminum adjuvants.
    Ulmer JB; DeWitt CM; Chastain M; Friedman A; Donnelly JJ; McClements WL; Caulfield MJ; Bohannon KE; Volkin DB; Evans RK
    Vaccine; 1999 Aug; 18(1-2):18-28. PubMed ID: 10501231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg].
    Du X; Wang J; Kang Y; Xiao W; Zhao G; Wang B
    Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):938-42. PubMed ID: 19873759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.